There was no "manipulation of patient data." The authors withdrew their raw data from a database, and then published the summary data (what most people will actually want to know) in a paper. The summary data matches the raw data (later recovered from the cloud).
> If the patient data had links to unpublished bat sequences the lab was working on, it would certainly be motivation to get rid of both.
The patient data had nothing to do with bat sequences. The paper we're talking about was a methodology paper, in which the authors were trying to test a new sequencing technology using recent patient samples. They were not focusing on SARS-CoV-2 origins, and they certainly weren't working with bat coronavirus sequences. I don't even think there's any connection to the WIV here: the corresponding authors don't appear to be affiliated with the institute.
There certainly was deliberate deletion of raw patient sequence data from the NCBI database. See the paper by Jesse D. Bloom that the NYT article references[1]. I would classify this as "manipulation".
The author is also puzzled why this was done if the data matches the published summary in the Wang et al. 2020b paper, but hasn't received any replies from the authors.
This is also interesting:
> Particularly in light of the directive that labs destroy early samples (Pingui 2020) and multiple orders requiring approval of publications on COVID-19 (China CDC 2020; Kang et al. 2020a), this suggests a less than wholehearted effort to maximize information about viral sequences from early in the Wuhan epidemic.
> I don't even think there's any connection to the WIV here: the corresponding authors don't appear to be affiliated with the institute.
The authors of the nanopore paper are associated with Wuhan University. Since the CCP controls all aspects of Chinese research it's safe to say that a connection with the WIV certainly exists and they would be in a position to control the output of both.
Again, the reason behind this will likely never be known to the outside world. But to take anything coming from Chinese researchers as evidence for a narrative that exculpates China from any fault would be extremely naive. Or do we really believe there's nothing suspicious about a country of 1.4bn people having 5,508 reported deaths from COVID-19[2]?
"Manipulation" means faking data, deliberately altering it, etc. What happened in this case is that the authors removed the raw data from a database and then published an accurate summary of the data in a peer-reviewed paper.
> Since the CCP controls all aspects of Chinese research
Not everything in China is automatically connected to everything else. People working on a new medical diagnostic tool at one university are not automatically related to people doing bat coronavirus research at another institute.
> Or do we really believe there's nothing suspicious about a country of 1.4bn people having 5,508 reported deaths from COVID-19[2]?
I'm sure there are lots of people here on HN who live in China, and who can explain the extremely strict and effective measures China took in early 2020 to eliminate SARS-CoV-2 from within their borders. China had a first wave that was largely confined to one city, and has had no large outbreak since. It's had small, local outbreaks that have been quickly contained. There's really no mystery about this at all.
> Could you link to this please?
It's in Table 1 of their June 2020 paper: https://onlinelibrary.wiley.com/doi/full/10.1002/smll.202002...
> If the patient data had links to unpublished bat sequences the lab was working on, it would certainly be motivation to get rid of both.
The patient data had nothing to do with bat sequences. The paper we're talking about was a methodology paper, in which the authors were trying to test a new sequencing technology using recent patient samples. They were not focusing on SARS-CoV-2 origins, and they certainly weren't working with bat coronavirus sequences. I don't even think there's any connection to the WIV here: the corresponding authors don't appear to be affiliated with the institute.